The role of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in colitis-induced hypersensitivity has been suggested. NGF and BDNF facilitate cellular physiology through binding to receptor tyrosine kinase TrkA and TrkB, respectively. The present study by examining the mRNA and/or protein levels of TrkA and TrkB in the distal colon and in colonic primary afferent neurons in the dorsal root ganglia (DRG) during colitis demonstrated that colitis elicited location-specific changes in the mRNA and protein levels of TrkA and TrkB in colonic primary sensory pathways. In colitis both the TrkA and TrkB protein levels were increased in the L1 and S1 DRGs in a time-dependent manner; however, the level of TrkB mRNA but not TrkA mRNA was increased in these DRGs. Further experiments showed that colitis facilitated a retrograde transport of TrkA protein toward and an anterograde transport of TrkA mRNA away from the DRG, which may contribute to the increased TrkA mRNA level in the distal colon during colitis. Colitis also increased the level of NGF mRNA but not BDNF mRNA in the distal colon. Double staining showed that the expression of TrkA but not TrkB was increased in the specifically labeled colonic afferent neurons in the L1 and S1 DRGs during colitis; this increase in TrkA level was attenuated by pretreatment with resiniferatoxin. These results suggested that colitis-induced primary afferent activation involved retrograde transport of TrkA but not TrkB from the distal colon to primary afferent neurons in DRG.
Introduction
Sensory neurons located in the dorsal root ganglia (DRG) play an important role in the regulation of peripheral function. In turn, irritation of peripheral organs also has significant effects on the activity of sensory neurons. This is also true for colonic inflammation (colitis) -induced neurochemical (e.g. neurotrophins and neurotrophin signal transduction [11, 32] ) and electrophysiological changes in the primary sensory pathways [3, 11, 20, 22, 29, 30, 32] . Systemic drug intervention by injecting antiserum of either nerve growth factor (NGF) or brain-derived neurotrophic factor (BDNF) intraperitoneally to rats with colonic inflammation reversed the associated colonic hypersensitivity [8] , suggesting a prominent role of NGF and BDNF in mediating the activity of colonic sensory pathways.
NGF and BDNF are members of the neurotrophin family that also include neurotrophin-3 (NT-3) and . The cellular effects of neurotrophins require their binding to specific receptors namely tropomyosin-receptor-kinase (Trk) [24] , a subfamily of receptor tyrosine kinase. Specifically, TrkA preferentially binds NGF; TrkB binds BDNF or NT-4/5; and TrkC binds . Recent studies demonstrate that NT-3 can also bind to TrkA and TrkB [36] . At embryonic stage, all sensory neurons contain TrkA; during development, some of the sensory neurons gradually lose TrkA and acquire different phenotypes [23] . At adulthood, TrkA and TrkB are mainly expressed in nociceptors [26, 28, 33, 34, 44] while TrkC is expressed in large proprioceptive sensory neurons [4, 26] , suggesting a distinct role of TrkA, TrkB and TrkC in mediating sensory activity.
Although all four neurotrophins are reported to play roles in neuronal growth, survival and differentiation [18] , NGF and BDNF are extensively reported to be involved in mediating sensory hypersensitivity [7] [8] [9] 12, 19, [33] [34] [35] 40] . Recent studies also suggested the involvement of NT-3 in the regulation of sensory neuron functions, however, a study of hind paw inflammation demonstrated an antagonistic function of NT-3 to NGF in which NT-3 reversed NGF-induced hind paw hyperalgesia [41] . This was probably due to the negative regulation of TrkA signaling by NT-3 in sensory neurons [41, 42] . Spinal intrathecal injection of BDNF or TrkB antisense or antiserum, but not TrkC-Fc, significantly blocked the inflammation-induced hypersensitivity [8, 12, 25, 43] . Based on these studies showing that TrkA and TrkB but not TrkC play primary roles in inducing sensory hypersensitivity during inflammation, we hypothesize that 
